Vivatides Therapeutics
Develops extrahepatic RNA-targeting therapeutics
$54MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops extrahepatic RNA-targeting therapeutics
Building a unified robotics foundation model for controlling robots
Pitching TF Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room